Michael Gwarisa Zimbabwe’s HIV response could face serious disruption following the Government’s decision to halt negotiations on a proposed US$350 million health funding agreement with the United States, public health experts have warned. The proposed agreement was being negotiated between the Government of Zimbabwe and the US Embassy in Harare, acting on behalf of Washington
Read More
By Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has announced the expedited approval of Lenacapavir, an innovative long-acting medicine for pre exposure prophylaxis (PrEP) to prevent HIV-1 infection. The MCAZ Director-General, Mr. Richard T. Rukwata, said “the rapid approval of Lenacapavir reflects the Authority’s dedication to accelerating access to trusted, high-quality health products
Read More
By Michael Gwarisa The United States Department of State, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has unveiled a new HIV and AIDS support fund worth US$65.1 million for Zimbabwe. The initiative, known as The Bridge Plan, will run for the next six months, with renewal contingent on the Government of Zimbabwe meeting
Read More
By Michael Gwarisa in Durban The Global Fund last night took to the platform at the ongoing 4th CPHIA Conference in Durban, South Africa, to call for support towards the 8th Replenishment, aimed at strengthening HIV programs amid shrinking donor support. The Global Fund’s 8th Replenishment is a campaign launched in 2025 to raise 18 billion
Read MoreBy Michael Gwarisa in Durban The Global Fund last night took to the platform at the ongoing 4th CPHIA Conference in Durban, South Africa, to call for support towards the 8th Replenishment, aimed at strengthening HIV programs amid shrinking donor support. The Global Fund’s 8th Replenishment is a campaign launched in 2025 to raise 18
Read More